Improved Urinary Cortisol Metabolome in Addison Disease: A Prospective Trial of Dual-Release Hydrocortisone

CONTEXT: Oral once-daily dual-release hydrocortisone (DR-HC) replacement therapy has demonstrated an improved metabolic profile compared to conventional 3-times-daily (TID-HC) therapy among patients with primary adrenal insufficiency. This effect might be related to a more physiological cortisol pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Espiard, Stéphanie, McQueen, Johanna, Sherlock, Mark, Ragnarsson, Oskar, Bergthorsdottir, Ragnhildur, Burman, Pia, Dahlqvist, Per, Ekman, Bertil, Engström, Britt Edén, Skrtic, Stanko, Wahlberg, Jeanette, Stewart, Paul M, Johannsson, Gudmundur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Clinical Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947853/
https://www.ncbi.nlm.nih.gov/pubmed/33236103
http://dx.doi.org/10.1210/clinem/dgaa862

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947853/
https://www.ncbi.nlm.nih.gov/pubmed/33236103
http://dx.doi.org/10.1210/clinem/dgaa862

Ejemplares similares